News tagged with 'Rofecoxib'

Promotion for the painkiller, Vioxx, took the form of entire phony medical journals, court documents reveal in the Australian class-action lawsuit underway.

Wanting to move on from the legacy of its deadly painkiller, the maker of Vioxx,  Merck & Co. this morning signed an agreement to pay $4.85 billion to settle the outstanding individual product liability claims against the drug. "This is

New Jersey Court Delivers Merck Legal Victory A New Jersey appeals panel has handed Merck & Co. a victory in the mass litigation over its painkiller Vioxx by barring 98 English and Welsh users of the drug from suing in the state's courts. The Vioxx plaintiffs wanted to take advantage

An editorial published in the December 2005 issue of the New England Journal of Medicine reveals that Vioxx maker Merck & Co. intentionally withheld documents showing that additional heart attacks were suffered during a clinical study of the recalled arthritis drug. According to the latest report, which was publish

The Food and Drug Administration (FDA) today acknowledged the voluntary withdrawal from the market of Vioxx (chemical name rofecoxib), a non-steroidal anti-inflammatory drug (NSAID) manufactured by Merck & Co. FDA today also issued a Public Health Advisory to inform patients of this action and to advise them to consu

The U.S. Food and Drug Administration (FDA) is reviewing two television commercials for Merck & Co. Inc.'s arthritis medication Vioxx due to the advertisements' failure to mention the drawbacks of the drug. In the first ad, Vioxx's name is mentioned but not its indication. The second mentions Vioxx's indication but n

A report in the October 5th issue of The Lancet summarizes a recent study linking high doses of the arthritis medication Vioxx (rofecoxib) to the development of coronary heart disease (CHD). As part of their research, physicians from Vanderbilt University analyzed data from 375,000 patients enrolled in the Tennessee M

According to a new report released today by one of the nation's largest pharmacy benefit managers, Express Scripts, COX-2 inhibitors such as Vioxx and Celebrex are often prescribed to patients who would just as likely benefit from far cheaper alternatives. COX-2 inhibitors are believed to be gentler on the body's dige

The makers of the anti-inflammatory medications Vioxx and Celebrex received more troubling news this week as a newly released study warned the drugs may delay bone healing. According to the report published in this month's issue of the Journal of Bone and Mineral Research, inhibiting cox-2, an enzyme that causes pain

A new study conducted by scientists at the University of Pennsylvania suggests that arthritis drugs such as Vioxx and Celebrex may increase a user's risk of suffering a heart attack. Lead scientist Dr. Garret Fitzgerald says the drugs may cause a chemical imbalance that prompts blood clots. Although the study examine

A new report published by the U.S. Food and Drug Administration (FDA) links Merck & Company's Vioxx to five cases of a nonbacterial type of meningitis. According to the FDA, several patients developed aseptic meningitis (inflammation of the covering around the brain and spinal cord) while using the arthritis drug. Th

The two most widely prescribed arthritis pain medications, Vioxx and Celebrex, have recently been linked to an increased risk of heart attacks. News about the unexpected link to cardiovascular problems has taken many people by surprise. Researchers note that the risk of heart attack caused by Vioxx or Celebrex is

In a recent letter to Merck & Co., the Food and Drug Administration (FDA) requested that the drug maker stop misrepresenting Vioxx's drug safety profile and diminishing its side effects. Of particular concern to FDA officials was Merck's cursory treatment of the risks of heart problems and excessive bleeding in patient

Drug makers Merck and Pharmacia are denying charges that the companies' popular arthritis drugs, Vioxx and Celebrex, may cause serious side effects. Both firms defend the benefits of their products and do not believe that safety tests requested by the American Heart Association, the National Stroke Association and the

The Journal of the American Medical Association recently published the results of a study linking the popular arthritis drugs Celebrex and Vioxx to an increased risk of stroke and heart attack. The popular cox-2 inhibiting drugs are marketed heavily and are increasingly prescribed. Researchers analyzed four studie